A Randomised Study of Docosahexaenoic Acid (DHA) in Metastatic Breast Cancer

Clinical trial NCT01548534 · TERMINATED

Trial details

NCT number: NCT01548534
Sponsor: University Hospital, Tours
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Breast Cancer Progesterone Receptor Positive Tumor Estrogen Receptor Positive Tumor HER-2 Negative Tumor

Start date: 2012-02-01
Primary completion: 2014-06-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.